Skip to main content
PEGASUS MERCANTILE INC. logo

PEGASUS MERCANTILE INC. — Investor Relations & Filings

Ticker · LOAN ISIN · CA70557Y2042 LEI · 529900BGK3BYC4VSF690 CSE Financial and insurance activities
Open in API
Filings indexed 424 across all filing types
Latest filing 2020-03-03 Regulatory Filings
Country CA Canada
Listing CSE LOAN

About PEGASUS MERCANTILE INC.

https://xtacytherapeutics.com/

Pegasus Mercantile Inc. is a diversified venture capital firm and prospect generator that provides financial, operational, and management assistance to high-growth companies. The firm specializes as an incubator for early-stage investments within the wellness consumer goods market, focusing on biotechnology, hemp, CBD, functional mushrooms, and psychedelics. Its investment strategy targets solutions for chronic pain, depression, and mental illness, often utilizing pioneering techniques such as micro-dosing organic and synthetic compounds. Pegasus Mercantile assists portfolio companies from startup through commercialization, specializing in navigating complex regulatory requirements, including clinical trials, patenting, and legislative approvals. The firm also provides debt financing facilities.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Regulatory Filings
2020-03-03 English
Interim financial statements/report – English.pdf
Regulatory Filings
2020-03-03 English
News release - English.pdf
Regulatory Filings
2020-02-11 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of the annual filings for the financial year ended September 30, 2019. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the annual filings but does not include them. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K) or other financial reports. The document length is 3133 characters, which is relatively short and consistent with a certification letter rather than a full report.
2020-01-29 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of annual filings including the AIF, annual financial statements, and annual MD&A for the fiscal year ended September 30, 2019. The document is a certification letter and does not contain actual financial statements or substantive financial data. It explicitly states it is a certification under National Instrument 52-109 and does not include representations about internal controls. The document length is short (3119 characters) and it serves as an officer certification rather than the full annual report or financial statements. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or Management Reports (MDA).
2020-01-29 English
Annual MD&A - English.pdf
Regulatory Filings
2020-01-29 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.